Mantovani, A.;                     Petracca, G.;                     Csermely, A.;                     Beatrice, G.;                     Targher, G.    
        Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. Metabolites 2021, 11, 22.
    https://doi.org/10.3390/metabo11010022
    AMA Style
    
                                Mantovani A,                                 Petracca G,                                 Csermely A,                                 Beatrice G,                                 Targher G.        
                Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. Metabolites. 2021; 11(1):22.
        https://doi.org/10.3390/metabo11010022
    
    Chicago/Turabian Style
    
                                Mantovani, Alessandro,                                 Graziana Petracca,                                 Alessandro Csermely,                                 Giorgia Beatrice,                                 and Giovanni Targher.        
                2021. "Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials" Metabolites 11, no. 1: 22.
        https://doi.org/10.3390/metabo11010022
    
    APA Style
    
                                Mantovani, A.,                                 Petracca, G.,                                 Csermely, A.,                                 Beatrice, G.,                                 & Targher, G.        
        
        (2021). Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. Metabolites, 11(1), 22.
        https://doi.org/10.3390/metabo11010022